Kuros Biosciences AG (SWX: KURN)
Switzerland
· Delayed Price · Currency is CHF
22.40
-1.95 (-8.01%)
Nov 21, 2024, 5:31 PM CET
Kuros Biosciences AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 915 | 128 | 54 | 63 | 66 | 55 | |
| Market Cap Growth | 761.67% | 138.81% | -14.90% | -4.70% | 20.42% | 59.08% | |
| Enterprise Value | 903 | 114 | 34 | 38 | 54 | 45 | |
| Last Close Price | 24.35 | 3.49 | 1.47 | 1.93 | 2.02 | 2.26 | |
| PS Ratio | 13.48 | 3.82 | 2.99 | 4.57 | 16.40 | 21.48 | |
| PB Ratio | 8.54 | 2.26 | 0.78 | 0.82 | 0.78 | 0.71 | |
| P/TBV Ratio | 22.80 | 8.15 | 2.67 | 3.01 | 2.45 | 3.42 | |
| EV/Sales Ratio | 17.18 | 3.41 | 1.90 | 2.77 | 13.27 | 17.71 | |
| Debt / Equity Ratio | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Asset Turnover | 0.68 | 0.43 | 0.21 | 0.15 | 0.04 | 0.03 | |
| Inventory Turnover | 1.14 | 1.27 | 1.47 | 2.33 | 1.96 | 2.96 | |
| Quick Ratio | 2.08 | 1.66 | 2.20 | 2.72 | 7.69 | 6.01 | |
| Current Ratio | 2.73 | 2.06 | 2.49 | 2.91 | 8.76 | 6.40 | |
| Return on Equity (ROE) | -14.32% | -21.86% | -20.02% | -9.33% | -14.18% | -14.58% | |
| Return on Assets (ROA) | -3.77% | -7.01% | -7.06% | -5.90% | -8.09% | -8.20% | |
| Return on Capital (ROIC) | -4.54% | -8.34% | -8.20% | -6.59% | -8.81% | -9.08% | |
| Earnings Yield | -1.28% | -10.70% | -27.17% | -11.95% | -17.39% | -20.45% | |
| FCF Yield | -0.35% | -7.14% | -14.41% | -9.13% | -14.04% | -19.88% | |
| Buyback Yield / Dilution | 17.17% | -7.91% | -3.37% | -34.86% | -53.69% | -81.36% | |
| Total Shareholder Return | 17.17% | -7.91% | -3.37% | -34.86% | -53.69% | -81.36% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.